Prosight Management, LP

Investment Portfolio & 13F Holdings Analysis

About
CIK: 0001617201
Type: FundHoldings: 38Value: $304.3MLatest: 2025Q1

Prosight Management, LP is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 38 holdings worth $0.3 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
38
Total Value
304343468
Accession Number
0001420506-25-001167
Form Type
13F-HR
Manager Name
Prosight-Management-Lp
Data Enrichment
100% identified
38 identified0 unidentified

Holdings

38 positions • $304.3M total value
Manager:
Search and click to pin securities to the top
Page 1 of 2
GALAPAGOS NV
Shares:1.3M
Value:$33.0M
% of Portfolio:10.9% ($33.0M/$304.3M)
MeiraGTx Holdings plc
Shares:3.7M
Value:$25.0M
% of Portfolio:8.2% ($25.0M/$304.3M)
BridgeBio Pharma, Inc.
Shares:610.0K
Value:$21.1M
% of Portfolio:6.9% ($21.1M/$304.3M)
Janux Therapeutics, Inc.
Shares:689.9K
Value:$18.6M
% of Portfolio:6.1% ($18.6M/$304.3M)
Roivant Sciences Ltd.
Shares:1.8M
Value:$18.4M
% of Portfolio:6.1% ($18.4M/$304.3M)
Mirum Pharmaceuticals, Inc.
Shares:343.3K
Value:$15.5M
% of Portfolio:5.1% ($15.5M/$304.3M)
Kura Oncology, Inc.
Shares:2.1M
Value:$13.7M
% of Portfolio:4.5% ($13.7M/$304.3M)
ADC Therapeutics SA
Shares:9.5M
Value:$13.5M
% of Portfolio:4.4% ($13.5M/$304.3M)
Zymeworks Inc.
Shares:957.2K
Value:$11.4M
% of Portfolio:3.7% ($11.4M/$304.3M)
AMICUS THERAPEUTICS, INC.
Shares:1.4M
Value:$11.3M
% of Portfolio:3.7% ($11.3M/$304.3M)
ICON PLC
Shares:60.1K
Value:$10.5M
% of Portfolio:3.5% ($10.5M/$304.3M)
ROCKET PHARMACEUTICALS, INC.
Shares:1.5M
Value:$9.9M
% of Portfolio:3.2% ($9.9M/$304.3M)
Acadia Healthcare Company, Inc.
Shares:290.0K
Value:$8.8M
% of Portfolio:2.9% ($8.8M/$304.3M)
ARGENX SE
Shares:13.7K
Value:$8.1M
% of Portfolio:2.7% ($8.1M/$304.3M)
Schrodinger, Inc.
Shares:385.0K
Value:$7.6M
% of Portfolio:2.5% ($7.6M/$304.3M)
Syndax Pharmaceuticals Inc
Shares:609.3K
Value:$7.5M
% of Portfolio:2.5% ($7.5M/$304.3M)
Tectonic Therapeutic, Inc.
Shares:398.9K
Value:$7.1M
% of Portfolio:2.3% ($7.1M/$304.3M)
INTUITIVE SURGICAL INC
Shares:14.0K
Value:$6.9M
% of Portfolio:2.3% ($6.9M/$304.3M)
Shattuck Labs, Inc.
Shares:6.6M
Value:$6.3M
% of Portfolio:2.1% ($6.3M/$304.3M)
AbCellera Biologics Inc.
Shares:2.8M
Value:$6.3M
% of Portfolio:2.1% ($6.3M/$304.3M)